BRIEF-Russia's State Wealth Fund Says Azerbaijan Okays Trials Of Sputnik V, AstraZeneca Vaccines

RUSSIAN DIRECT INVESTMENT FUND: * AZERBAIJAN ISSUES PERMIT TO CONDUCT WORLD'S FIRST CLINICAL TRIALS OF VACCINE COMBINATION - SPUTNIK V AND THE ASTRAZENECA COVID-19 VACCINE

* RUSSIAN DIRECT INVESTMENT FUND - CLINICAL TRIALS OF COMBINATION OF SPUTNIK V AND ASTRAZENECA VACCINES WILL BEGIN IN FEBRUARY 2021 * RDIF - STUDY TO ALLOW EVALUATING IMMUNOGENICITY & SAFETY OF COMBINED USE OF SPUTNIK V & VACCINE JOINTLY DEVELOPED BY ASTRAZENECA AND OXFORD UNIVERSITY

* RUSSIAN DIRECT INVESTMENT FUND - RESEARCH WILL BE CARRIED OUT OVER COURSE OF SIX MONTHS IN SEVERAL COUNTRIES WITH 100 VOLUNTEERS RECRUITED IN EACH Source text for Eikon: Further company coverage:

Also Read: BRIEF-AstraZeneca Says Calquence Met Primary Endpoint Against Ibrutinib